CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoGATTI, MILO
Dettaglio
GATTI, MILO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
Pubblicazioni
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.002 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria | Gatti M.; Giannella M.; Scudeller L.; Viale P. | 2020 | THE LANCET INFECTIOUS DISEASES | 1.04 Replica / breve intervento (e simili) | - | |
| 2 | Advances in the therapy of bacterial bloodstream infections | Giannella M.; Bartoletti M.; Gatti M.; Viale P. | 2020 | CLINICAL MICROBIOLOGY AND INFECTION | 1.01 Articolo in rivista | - | |
| 3 | Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi | 2020 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 1.01 Articolo in rivista | ||
| 4 | Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review | Gatti M.; Bianchin M.; Raschi E.; De Ponti F. | 2020 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | 1.01 Articolo in rivista | - | |
| 5 | Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing | Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio | 2021 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1.01 Articolo in rivista | - | |
| 6 | Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews | Raschi E.; Bianchin M.; Gatti M.; Squizzato A.; De Ponti F. | 2019 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
| 7 | The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia | Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I. | 2020 | CURRENT HEART FAILURE REPORTS | 1.01 Articolo in rivista | - | |
| 8 | In vivo acquisition and risk of inter-species spread of blaKPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract | Bielli A.; Piazza A.; Cento V.; Comandatore F.; Lepera V.; Gatti M.; Brioschi P.; Vismara C.; Ban...di C.; Perno C.F. | 2020 | JOURNAL OF MEDICAL MICROBIOLOGY | 1.01 Articolo in rivista | - | |
| 9 | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase | Gatti, Milo; Raschi, Emanuel; Moretti, Ugo; Ardizzoni, Andrea; Poluzzi, Elisabetta; Diemberger, Igor | 2021 | VACCINES | 1.01 Articolo in rivista | - | |
| 10 | Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance | Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F. | 2020 | TARGETED ONCOLOGY | 1.01 Articolo in rivista | - | |
| 11 | Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis | Gatti M.; Poluzzi E.; De Ponti F.; Raschi E. | 2020 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
| 12 | Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shock | Gatti M. | 2020 | JOURNAL OF CHEMOTHERAPY | 1.01 Articolo in rivista | - | |
| 13 | Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study | Cento V.; Alteri C.; Mancini V.; Gatti M.; Lepera V.; Mazza E.; Moioli M.C.; Merli M.; Colombo J....; Orcese C.A.; Bielli A.; Torri S.; Gasparini L.E.; Vismara C.; De Gasperi A.; Brioschi P.; Puoti M.; Cairoli R.; Lombardi G.; Perno C.F. | 2020 | MYCOSES | 1.01 Articolo in rivista | - | |
| 14 | Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study | Gatti M.; Raschi E.; De Ponti F. | 2019 | BMC PHARMACOLOGY & TOXICOLOGY | 1.01 Articolo in rivista | ||
| 15 | Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements | Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Ma...zzanti G.; De Ponti F.; Raschi E. | 2020 | CLINICAL NUTRITION | 1.04 Replica / breve intervento (e simili) | - | |
| 16 | Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis | Pujade I.; Perino J.; Mathieu C.; Arnaud M.; Raschi E.; Gatti M.; Bezin J.; Salvo F. | 2020 | PHARMACOLOGICAL RESEARCH | 1.01 Articolo in rivista | - | |
| 17 | Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections? | Gatti, Milo; Pea, Federico | 2021 | CLINICAL PHARMACOKINETICS | 1.01 Articolo in rivista | - |
Copyright © 2021